Uwaydah M, Vartivarian S, Shatila S, Raad I, Harakeh H, Nassar N T
Antimicrob Agents Chemother. 1986 Aug;30(2):338-9. doi: 10.1128/AAC.30.2.338.
Moxalactam therapy was evaluated in 25 patients with typhoid fever. A satisfactory initial response was observed in all cases. Treatment for 3 days resulted in a much higher relapse rate (three of five patients) than did treatment for 5 days (one of nine patients). None of the 11 patients treated for 10 to 11 days relapsed. Moxalactam is effective in typhoid fever, but its use is better restricted to special indications.
对25例伤寒患者进行了羟羧氧酰胺菌素治疗评估。所有病例均观察到令人满意的初始反应。治疗3天的复发率(5例中有3例)远高于治疗5天的复发率(9例中有1例)。接受10至11天治疗的11例患者均未复发。羟羧氧酰胺菌素对伤寒有效,但最好仅限于特殊适应症使用。